Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005920 · ClinicalTrials.gov registry record · Phase 2
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
A Phase 2 study, sponsored by Merck Sharp & Dohme.
- Terminated
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00005920 is a Phase 2 study that was terminated before completion, run by Merck Sharp & Dohme. The registered enrollment target is 70 participants.
The verdict
NCT00005920, a Phase 2 study, was terminated before completion, sponsored by Merck Sharp & Dohme.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to see if it is safe and effective to give L-743,872 to patients with thrush, an AIDS-related yeast infection of the mouth, that has not been cured with fluconazole treatment.
Interventions
- DRUG L-743,872
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005920
The ClinicalTrials.gov registry entry for NCT00005920 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merck Sharp & Dohme, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-743,872 is the first listed.
NCT00005920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005920 about?
NCT00005920 is a clinical study titled "Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole". The purpose of this study is to see if it is safe and effective to give L-743,872 to patients with thrush, an AIDS-related yeast infection of the mouth, that has not been cured with fluconazole treatment.
What is the current status of trial NCT00005920?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 70 participants.
What interventions are being tested in trial NCT00005920?
The interventions under investigation include: L-743,872 (DRUG).
Who is sponsoring clinical trial NCT00005920?
This trial is sponsored by Merck Sharp & Dohme, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.